nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP2J2—artery—metabolic syndrome X	0.0474	0.237	CbGeAlD
Rivaroxaban—CYP2J2—blood vessel—metabolic syndrome X	0.0369	0.184	CbGeAlD
Rivaroxaban—F10—cardiovascular system—metabolic syndrome X	0.0201	0.1	CbGeAlD
Rivaroxaban—Toothache—Metformin—metabolic syndrome X	0.0178	0.0833	CcSEcCtD
Rivaroxaban—F10—adipose tissue—metabolic syndrome X	0.0177	0.0885	CbGeAlD
Rivaroxaban—CYP2J2—cardiovascular system—metabolic syndrome X	0.0165	0.0823	CbGeAlD
Rivaroxaban—F10—liver—metabolic syndrome X	0.0124	0.0621	CbGeAlD
Rivaroxaban—Contusion—Metformin—metabolic syndrome X	0.0124	0.0581	CcSEcCtD
Rivaroxaban—CYP2J2—liver—metabolic syndrome X	0.0102	0.0509	CbGeAlD
Rivaroxaban—Pain in extremity—Metformin—metabolic syndrome X	0.00785	0.0368	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Metformin—metabolic syndrome X	0.00717	0.0336	CcSEcCtD
Rivaroxaban—ABCB1—blood vessel—metabolic syndrome X	0.00691	0.0345	CbGeAlD
Rivaroxaban—Angina pectoris—Metformin—metabolic syndrome X	0.00661	0.031	CcSEcCtD
Rivaroxaban—Infestation—Metformin—metabolic syndrome X	0.00605	0.0283	CcSEcCtD
Rivaroxaban—Infestation NOS—Metformin—metabolic syndrome X	0.00605	0.0283	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00572	0.0268	CcSEcCtD
Rivaroxaban—CYP3A5—kidney—metabolic syndrome X	0.00568	0.0283	CbGeAlD
Rivaroxaban—Hepatitis—Metformin—metabolic syndrome X	0.00543	0.0254	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Metformin—metabolic syndrome X	0.00534	0.025	CcSEcCtD
Rivaroxaban—CYP3A5—adipose tissue—metabolic syndrome X	0.00512	0.0255	CbGeAlD
Rivaroxaban—Eye disorder—Metformin—metabolic syndrome X	0.00508	0.0238	CcSEcCtD
Rivaroxaban—Cardiac disorder—Metformin—metabolic syndrome X	0.00504	0.0236	CcSEcCtD
Rivaroxaban—Angiopathy—Metformin—metabolic syndrome X	0.00493	0.0231	CcSEcCtD
Rivaroxaban—Immune system disorder—Metformin—metabolic syndrome X	0.00491	0.023	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Metformin—metabolic syndrome X	0.00489	0.0229	CcSEcCtD
Rivaroxaban—Muscle spasms—Metformin—metabolic syndrome X	0.00455	0.0213	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Metformin—metabolic syndrome X	0.00439	0.0206	CcSEcCtD
Rivaroxaban—Malaise—Metformin—metabolic syndrome X	0.00426	0.02	CcSEcCtD
Rivaroxaban—CYP3A4—kidney—metabolic syndrome X	0.00426	0.0213	CbGeAlD
Rivaroxaban—Syncope—Metformin—metabolic syndrome X	0.00424	0.0199	CcSEcCtD
Rivaroxaban—Loss of consciousness—Metformin—metabolic syndrome X	0.00416	0.0195	CcSEcCtD
Rivaroxaban—Chest pain—Metformin—metabolic syndrome X	0.00403	0.0189	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.004	0.0187	CcSEcCtD
Rivaroxaban—Discomfort—Metformin—metabolic syndrome X	0.00398	0.0186	CcSEcCtD
Rivaroxaban—Oedema—Metformin—metabolic syndrome X	0.00386	0.0181	CcSEcCtD
Rivaroxaban—Infection—Metformin—metabolic syndrome X	0.00383	0.018	CcSEcCtD
Rivaroxaban—Shock—Metformin—metabolic syndrome X	0.0038	0.0178	CcSEcCtD
Rivaroxaban—Nervous system disorder—Metformin—metabolic syndrome X	0.00378	0.0177	CcSEcCtD
Rivaroxaban—Skin disorder—Metformin—metabolic syndrome X	0.00375	0.0176	CcSEcCtD
Rivaroxaban—Hypotension—Metformin—metabolic syndrome X	0.00361	0.0169	CcSEcCtD
Rivaroxaban—CYP3A5—liver—metabolic syndrome X	0.00359	0.0179	CbGeAlD
Rivaroxaban—Dyspnoea—Metformin—metabolic syndrome X	0.00344	0.0161	CcSEcCtD
Rivaroxaban—Dyspepsia—Metformin—metabolic syndrome X	0.0034	0.0159	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00333	0.0156	CcSEcCtD
Rivaroxaban—Fatigue—Metformin—metabolic syndrome X	0.00333	0.0156	CcSEcCtD
Rivaroxaban—Constipation—Metformin—metabolic syndrome X	0.0033	0.0155	CcSEcCtD
Rivaroxaban—Feeling abnormal—Metformin—metabolic syndrome X	0.00318	0.0149	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00316	0.0148	CcSEcCtD
Rivaroxaban—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.00315	0.00537	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—GGT1—metabolic syndrome X	0.00311	0.00531	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.0031	0.00529	CbGpPWpGaD
Rivaroxaban—ABCB1—cardiovascular system—metabolic syndrome X	0.00308	0.0154	CbGeAlD
Rivaroxaban—Urticaria—Metformin—metabolic syndrome X	0.00307	0.0144	CcSEcCtD
Rivaroxaban—Abdominal pain—Metformin—metabolic syndrome X	0.00305	0.0143	CcSEcCtD
Rivaroxaban—ABCB1—kidney—metabolic syndrome X	0.00302	0.0151	CbGeAlD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.003	0.00511	CbGpPWpGaD
Rivaroxaban—Asthenia—Metformin—metabolic syndrome X	0.00277	0.013	CcSEcCtD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.00274	0.00468	CbGpPWpGaD
Rivaroxaban—Pruritus—Metformin—metabolic syndrome X	0.00273	0.0128	CcSEcCtD
Rivaroxaban—ABCB1—adipose tissue—metabolic syndrome X	0.00272	0.0136	CbGeAlD
Rivaroxaban—CYP3A4—liver—metabolic syndrome X	0.00269	0.0134	CbGeAlD
Rivaroxaban—Diarrhoea—Metformin—metabolic syndrome X	0.00264	0.0124	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—FMO3—metabolic syndrome X	0.00261	0.00445	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00257	0.00439	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00256	0.00436	CbGpPWpGaD
Rivaroxaban—Dizziness—Metformin—metabolic syndrome X	0.00255	0.012	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.00248	0.00423	CbGpPWpGaD
Rivaroxaban—Vomiting—Metformin—metabolic syndrome X	0.00245	0.0115	CcSEcCtD
Rivaroxaban—Rash—Metformin—metabolic syndrome X	0.00243	0.0114	CcSEcCtD
Rivaroxaban—Dermatitis—Metformin—metabolic syndrome X	0.00243	0.0114	CcSEcCtD
Rivaroxaban—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.00243	0.00414	CbGpPWpGaD
Rivaroxaban—Headache—Metformin—metabolic syndrome X	0.00242	0.0113	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.00235	0.00401	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00229	0.00391	CbGpPWpGaD
Rivaroxaban—Nausea—Metformin—metabolic syndrome X	0.00229	0.0107	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00228	0.0039	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.00204	0.00349	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—PLA2G7—metabolic syndrome X	0.00203	0.00346	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.002	0.00341	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.00193	0.0033	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—GCK—metabolic syndrome X	0.00193	0.0033	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.00191	0.00327	CbGpPWpGaD
Rivaroxaban—ABCB1—liver—metabolic syndrome X	0.00191	0.00952	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.00178	0.00304	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00177	0.00302	CbGpPWpGaD
Rivaroxaban—ABCB1—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	0.00159	0.00271	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.00159	0.00271	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.00158	0.00269	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00158	0.00269	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—FMO3—metabolic syndrome X	0.00155	0.00264	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.00153	0.00261	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.00147	0.0025	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00146	0.0025	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.00142	0.00243	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.00138	0.00236	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—EPHX2—metabolic syndrome X	0.00138	0.00235	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MLXIPL—metabolic syndrome X	0.00138	0.00235	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—G6PC2—metabolic syndrome X	0.0013	0.00221	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.00123	0.0021	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.00121	0.00207	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.0012	0.00204	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.0012	0.00204	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—GHRL—metabolic syndrome X	0.00118	0.00202	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IGF2—metabolic syndrome X	0.00117	0.00199	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—ACE—metabolic syndrome X	0.00115	0.00196	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—APOB—metabolic syndrome X	0.00113	0.00193	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—FABP4—metabolic syndrome X	0.0011	0.00188	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PLA2G4A—metabolic syndrome X	0.0011	0.00188	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00109	0.00186	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00107	0.00182	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HSD11B1—metabolic syndrome X	0.00105	0.00178	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CD36—metabolic syndrome X	0.00103	0.00175	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.00101	0.00173	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—LEP—metabolic syndrome X	0.000989	0.00169	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000986	0.00168	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000968	0.00165	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—G6PD—metabolic syndrome X	0.000932	0.00159	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.00092	0.00157	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—IGF2—metabolic syndrome X	0.000917	0.00156	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HDAC3—metabolic syndrome X	0.00091	0.00155	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000902	0.00154	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GGT1—metabolic syndrome X	0.000897	0.00153	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—APOA1—metabolic syndrome X	0.000895	0.00153	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LPA—metabolic syndrome X	0.000889	0.00152	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GCKR—metabolic syndrome X	0.000889	0.00152	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLA2G6—metabolic syndrome X	0.000861	0.00147	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000855	0.00146	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOA5—metabolic syndrome X	0.000853	0.00145	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000828	0.00141	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000812	0.00138	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000802	0.00137	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TRIB3—metabolic syndrome X	0.000793	0.00135	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—metabolic syndrome X	0.000776	0.00132	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IGF1—metabolic syndrome X	0.000748	0.00128	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—AGT—metabolic syndrome X	0.000727	0.00124	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—LEP—metabolic syndrome X	0.000712	0.00122	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NAMPT—metabolic syndrome X	0.000711	0.00121	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SERPINE1—metabolic syndrome X	0.000711	0.00121	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ALB—metabolic syndrome X	0.000709	0.00121	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000707	0.00121	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LIPC—metabolic syndrome X	0.000707	0.00121	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GCK—metabolic syndrome X	0.000707	0.00121	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOC3—metabolic syndrome X	0.000702	0.0012	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CETP—metabolic syndrome X	0.000682	0.00116	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS3—metabolic syndrome X	0.000678	0.00116	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—SCARB1—metabolic syndrome X	0.000653	0.00111	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000636	0.00108	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—SREBF1—metabolic syndrome X	0.000634	0.00108	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GOT2—metabolic syndrome X	0.000617	0.00105	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HMGCR—metabolic syndrome X	0.000617	0.00105	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—INS—metabolic syndrome X	0.000609	0.00104	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000603	0.00103	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CCL2—metabolic syndrome X	0.000599	0.00102	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—IGF1—metabolic syndrome X	0.000589	0.001	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000556	0.000949	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCA1—metabolic syndrome X	0.00055	0.000937	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—SLC2A4—metabolic syndrome X	0.00055	0.000937	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000536	0.000914	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GOT1—metabolic syndrome X	0.000532	0.000908	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GGT1—metabolic syndrome X	0.000532	0.000908	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.000514	0.000876	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOB—metabolic syndrome X	0.000452	0.00077	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TGFB1—metabolic syndrome X	0.000449	0.000765	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FMO3—metabolic syndrome X	0.000446	0.000761	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLA2G4A—metabolic syndrome X	0.000439	0.000749	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LPL—metabolic syndrome X	0.000431	0.000735	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	0.000424	0.000724	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000417	0.000711	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.000413	0.000704	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CD36—metabolic syndrome X	0.00041	0.000699	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—EPHX2—metabolic syndrome X	0.000398	0.000679	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MLXIPL—metabolic syndrome X	0.000398	0.000679	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	0.000396	0.000676	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARA—metabolic syndrome X	0.000381	0.00065	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—G6PC2—metabolic syndrome X	0.000374	0.000638	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AGT—metabolic syndrome X	0.000369	0.000629	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOE—metabolic syndrome X	0.000361	0.000616	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOA1—metabolic syndrome X	0.000357	0.000609	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000349	0.000596	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	0.000341	0.000581	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FMO3—metabolic syndrome X	0.000337	0.000574	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.000328	0.00056	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FABP4—metabolic syndrome X	0.000318	0.000542	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.000317	0.00054	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—metabolic syndrome X	0.000315	0.000537	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—AKT1—metabolic syndrome X	0.000312	0.000532	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—INS—metabolic syndrome X	0.000309	0.000527	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HSD11B1—metabolic syndrome X	0.000302	0.000514	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	0.0003	0.000512	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—EPHX2—metabolic syndrome X	0.0003	0.000512	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.00029	0.000494	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—metabolic syndrome X	0.000283	0.000483	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—G6PC2—metabolic syndrome X	0.000282	0.000481	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—metabolic syndrome X	0.000271	0.000462	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—G6PD—metabolic syndrome X	0.000269	0.000458	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HDAC3—metabolic syndrome X	0.000262	0.000447	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCKR—metabolic syndrome X	0.000256	0.000437	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPA—metabolic syndrome X	0.000256	0.000437	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000255	0.000435	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G6—metabolic syndrome X	0.000248	0.000423	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—metabolic syndrome X	0.000248	0.000422	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA5—metabolic syndrome X	0.000246	0.000419	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FABP4—metabolic syndrome X	0.00024	0.000409	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TRIB3—metabolic syndrome X	0.000228	0.00039	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	0.000228	0.000388	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.00021	0.000358	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000209	0.000357	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000208	0.000354	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NAMPT—metabolic syndrome X	0.000205	0.00035	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LIPC—metabolic syndrome X	0.000204	0.000347	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCK—metabolic syndrome X	0.000204	0.000347	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—G6PD—metabolic syndrome X	0.000203	0.000346	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOC3—metabolic syndrome X	0.000202	0.000345	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HDAC3—metabolic syndrome X	0.000198	0.000338	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CETP—metabolic syndrome X	0.000196	0.000335	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000196	0.000334	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCKR—metabolic syndrome X	0.000193	0.00033	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPA—metabolic syndrome X	0.000193	0.00033	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SCARB1—metabolic syndrome X	0.000188	0.000321	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	0.000187	0.00032	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA5—metabolic syndrome X	0.000185	0.000316	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000185	0.000315	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000185	0.000315	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SREBF1—metabolic syndrome X	0.000183	0.000312	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMGCR—metabolic syndrome X	0.000178	0.000303	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT2—metabolic syndrome X	0.000178	0.000303	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.000177	0.000302	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000174	0.000297	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TRIB3—metabolic syndrome X	0.000172	0.000294	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.000166	0.000283	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCA1—metabolic syndrome X	0.000158	0.00027	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC2A4—metabolic syndrome X	0.000158	0.00027	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NAMPT—metabolic syndrome X	0.000155	0.000264	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCK—metabolic syndrome X	0.000154	0.000262	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LIPC—metabolic syndrome X	0.000154	0.000262	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GGT1—metabolic syndrome X	0.000153	0.000262	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT1—metabolic syndrome X	0.000153	0.000262	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOC3—metabolic syndrome X	0.000153	0.00026	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CETP—metabolic syndrome X	0.000148	0.000253	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000148	0.000252	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000146	0.000248	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SCARB1—metabolic syndrome X	0.000142	0.000242	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.00014	0.000239	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SREBF1—metabolic syndrome X	0.000138	0.000235	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT2—metabolic syndrome X	0.000134	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMGCR—metabolic syndrome X	0.000134	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.000131	0.000224	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOB—metabolic syndrome X	0.00013	0.000222	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	0.000127	0.000216	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—G6PD—metabolic syndrome X	0.000125	0.000213	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—metabolic syndrome X	0.000124	0.000212	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPL—metabolic syndrome X	0.000124	0.000212	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	0.000122	0.000208	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCA1—metabolic syndrome X	0.00012	0.000204	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	0.00012	0.000204	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCKR—metabolic syndrome X	0.000119	0.000203	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPA—metabolic syndrome X	0.000119	0.000203	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CD36—metabolic syndrome X	0.000118	0.000201	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GGT1—metabolic syndrome X	0.000116	0.000197	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT1—metabolic syndrome X	0.000116	0.000197	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	0.000115	0.000197	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA5—metabolic syndrome X	0.000114	0.000195	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARA—metabolic syndrome X	0.00011	0.000187	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AGT—metabolic syndrome X	0.000106	0.000181	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	0.000106	0.000181	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOE—metabolic syndrome X	0.000104	0.000178	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA1—metabolic syndrome X	0.000103	0.000176	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOB—metabolic syndrome X	9.82e-05	0.000168	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	9.55e-05	0.000163	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	9.53e-05	0.000163	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LIPC—metabolic syndrome X	9.47e-05	0.000161	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCK—metabolic syndrome X	9.47e-05	0.000161	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOC3—metabolic syndrome X	9.41e-05	0.00016	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPL—metabolic syndrome X	9.38e-05	0.00016	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CETP—metabolic syndrome X	9.13e-05	0.000156	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—metabolic syndrome X	9.07e-05	0.000155	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CD36—metabolic syndrome X	8.91e-05	0.000152	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—INS—metabolic syndrome X	8.9e-05	0.000152	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	8.75e-05	0.000149	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	8.49e-05	0.000145	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARA—metabolic syndrome X	8.28e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	8.26e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT2—metabolic syndrome X	8.26e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—metabolic syndrome X	8.16e-05	0.000139	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AGT—metabolic syndrome X	8.02e-05	0.000137	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOE—metabolic syndrome X	7.86e-05	0.000134	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—metabolic syndrome X	7.8e-05	0.000133	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA1—metabolic syndrome X	7.77e-05	0.000133	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	7.36e-05	0.000126	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	7.36e-05	0.000126	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	7.14e-05	0.000122	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT1—metabolic syndrome X	7.13e-05	0.000122	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GGT1—metabolic syndrome X	7.13e-05	0.000122	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—metabolic syndrome X	6.85e-05	0.000117	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—INS—metabolic syndrome X	6.72e-05	0.000115	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—metabolic syndrome X	6.16e-05	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOB—metabolic syndrome X	6.05e-05	0.000103	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—metabolic syndrome X	5.89e-05	0.0001	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	5.89e-05	0.0001	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPL—metabolic syndrome X	5.78e-05	9.85e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CD36—metabolic syndrome X	5.49e-05	9.36e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—metabolic syndrome X	5.39e-05	9.19e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.1e-05	8.71e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AGT—metabolic syndrome X	4.94e-05	8.43e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOE—metabolic syndrome X	4.84e-05	8.26e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA1—metabolic syndrome X	4.79e-05	8.17e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.22e-05	7.2e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—INS—metabolic syndrome X	4.14e-05	7.06e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.79e-05	6.47e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.63e-05	6.19e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—metabolic syndrome X	3.59e-05	6.12e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.32e-05	5.66e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—metabolic syndrome X	2.71e-05	4.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.67e-05	2.84e-05	CbGpPWpGaD
